Navigation Links
Angiotech announces results for the fourth quarter ended December 31, 2007
Date:2/14/2008

.

ANGIOTECH PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(in thousands of

U.S.$, except

share and per Three months ended Three months ended

share data) December 31, 2007 December 31, 2006

-------------------------------------------------------------------------

Adjust- Adjust-

Reported ments Adjusted Reported ments Adjusted

REVENUE

Royalty revenue 27,158 27,158 47,475 (9,000)a 38,475

Product sales, net 43,935 (401)b 43,534 44,726 44,726

License fees 266 (266)c - 1,052 (1,052)c -

-------------------------------------------------------------------------

71,359 (667) 70,692 93,253 (10,052) 83,201

-------------------------------------------------------------------------

EXPENSES

License and royalty

fees 4,527 4,527 6,048 6,048

Cost of products

sold 24,158 (665)d 23,493 22,465 22,465

Research and

development 13,556 (150)e 13,406 12,165 (500)e 11,665

Selling, general

and administrative 27,180 (3,674)f 23,506 24,227 (6,229)f 17,998

Depreciation and

amortization 8,826 (7,993)g 833 14,288 (13,316)g 972

In-process research

and development 125 (125)h -

-------------------------------------------------------------------------

78,372 (12,607) 65,765 79,193 (20,045) 59,148

-------------------------------------------------------------------------

Operating (loss)

income (7,013) 11,940
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...ciences, Inc.,(OTC Bulletin Board: DSCI), a provid...s increased its direct-sales staff significantly, ... favor in target markets. The,company, which had o...now,has nine, and will move to 21 by 2009. The inc...ch has been growing sales at an accelerating rate,...
...t 7:00 p.m. Eastern Time in Conjunction with ...e - REDWOOD CITY, Calif. and SUNNYVALE, Calif.,...tive,Surgical, Inc. (Nasdaq: ISRG ) today announc...c of "Advanced Techniques and Technologies in Robo...pair." The symposium will,feature Intuitive,s da V...
...tinue pre-adoption clinical evaluation of ...CJD now means that all the population is susceptib... Increased concerns over "second wave" of vCJD in ...r incubation times - P-Capt(R) prion reduction f... against potential transmission of the disease in ...
Other Biology Technology:Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 2Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 3Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 2Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 3Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 4Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 5ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 2ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 3ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 4ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 5
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
(Date:12/3/2009)PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Fish with attitude: Some like it hot 2WellGen Recognized as Nutraceutical 26amp 3B 238220 3BInnovator 26amp 3B 238221 3B by Global Business Insights 14888 1WellGen Recognized as Nutraceutical 26amp 3B 238220 3BInnovator 26amp 3B 238221 3B by Global Business Insights 14888 2WellGen Recognized as Nutraceutical 26amp 3B 238220 3BInnovator 26amp 3B 238221 3B by Global Business Insights 14888 3Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 1Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 2Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 3Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 4AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 1AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 2
...ifficult to eliminate tumours effectively. Deciph...e immune system,s effect on tumour cells and thus ...mmune therapy. At the Institut Curie, INSERM and ...o demonstrate, for the first time in vivo and real... in order to fight it. , These "defenders" methodi...
...n examine single molecules in order to determine g...ore accurately examine single cancer cells, has be...rchers at UCLA,s California Nanosystems Institute...f Mathematical Sciences, and Veeco Instruments, a ...January issue of the journal Nanotechnology. , Pr...
... have discovered that the same ingredient used in ...d flaking on your head also can calm overexcited n... treatment for seizures. Results of the study can ...lepsy and other seizure disorders result when nerv...in. The brain’s “off?switches fail in part due to ...
Other Biology News:How T lymphocytes attack 2How T lymphocytes attack 3Anti-dandruff compound may help fight epilepsy 2
Corning Culture Flask, 25 cm2, Tc-Treated, Angled Neck, Phenolic-Style Cap, Sterile from Sigma-Aldrich
LIC Duet™ T7•Tag® Ek Adaptor from Novagen
Corning Culture Flask, 75 cm2, Tc-Treated, Straight Neck, Phenolic-Style Cap, Sterile from Sigma-Aldrich
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Novus Biologicals
Biology Products: